Literature DB >> 1467053

Myocardial disarray in Noonan syndrome.

M Burch1, J M Mann, M Sharland, E A Shinebourne, M A Patton, W J McKenna.   

Abstract

OBJECTIVE: To characterise the histopathology of the left ventricular hypertrophy commonly associated with Noonan syndrome by assessing the extent of myocyte disarray and therefore to define one aspect of the relation between this disease and idiopathic hypertrophic cardiomyopathy.
DESIGN: Blinded histological analysis.
SETTING: Hospital medical school. PATIENTS: Six hearts of children with the Noonan phenotype and isolated ventricular hypertrophy were compared with age and sex matched controls.
METHODS: Histological analysis was performed with an image analyser under light microscopy. Representative sections from the entire left ventricular free wall were examined. Results were expressed as the percentage of fields showing disarray related to the number of fields evaluated: 100 fields were examined for each patient.
RESULTS: In the patients with Noonan syndrome myocardial disarray was present in the ventricular septum in 24 (5.7)% (mean (SD)) of fields and in the free wall in 22.2 (6.8)%. In the controls disarray was present in the septum in 3.8 (2.3)% of fields and in the free wall in 2.4 (2.8)%. In both regions the extent of disarray was significantly greater in patients with Noonan syndrome (p < 0.0005; 95% confidence interval 14 to 26.3 for the septum: p < 0.005, 95% confidence interval 11.4 to 28.2 for the free wall).
CONCLUSIONS: The ventricular hypertrophy associated with Noonan syndrome is histologically similar to hypertrophic cardiomyopathy but whether the two diseases are the expression of the same genetic defect remains to be determined.

Entities:  

Mesh:

Year:  1992        PMID: 1467053      PMCID: PMC1025689          DOI: 10.1136/hrt.68.12.586

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  15 in total

1.  Mapping a gene for familial hypertrophic cardiomyopathy to chromosome 14q1.

Authors:  J A Jarcho; W McKenna; J A Pare; S D Solomon; R F Holcombe; S Dickie; T Levi; H Donis-Keller; J G Seidman; C E Seidman
Journal:  N Engl J Med       Date:  1989-11-16       Impact factor: 91.245

2.  Hypertrophic cardiomyopathy: one disease or several?

Authors:  M J Davies
Journal:  Br Heart J       Date:  1990-05

3.  Eccentric ventricular hypertrophy in familial and sporadic instances of 46 XX, XY Turner phenotype.

Authors:  K H Ehlers; M A Engle; A R Levin; W J Deely
Journal:  Circulation       Date:  1972-03       Impact factor: 29.690

4.  Quantitative analysis of cardiac muscle cell disorganization in the ventricular septum of patients with hypertrophic cardiomyopathy.

Authors:  B J Maron; W C Roberts
Journal:  Circulation       Date:  1979-04       Impact factor: 29.690

5.  Quantitative analysis of the distribution of cardiac muscle cell disorganization in the left ventricular wall of patients with hypertrophic cardiomyopathy.

Authors:  B J Maron; T J Anan; W C Roberts
Journal:  Circulation       Date:  1981-04       Impact factor: 29.690

6.  Echocardiographic studies of left ventricular disease in Ullrich-Noonan syndrome.

Authors:  J J Nora; R H Lortscher; R D Spangler
Journal:  Am J Dis Child       Date:  1975-12

7.  Rapidly progressive obstructive cardiomyopathy in infants with Noonan's syndrome. Report of two cases.

Authors:  H D Hirsch; H Gelband; O Garcia; S Gottlieb; D M Tamer
Journal:  Circulation       Date:  1975-12       Impact factor: 29.690

8.  Quantitative analysis of cardiac muscle cell disorganization in the ventricular septum. Comparison of fetuses and infants with and without congenital heart disease and patients with hypertrophic cardiomyopathy.

Authors:  B J Maron; N Sato; W C Roberts; J E Edwards; R S Chandra
Journal:  Circulation       Date:  1979-09       Impact factor: 29.690

9.  Hypertrophic cardiomyopathy: an important cause of sudden death.

Authors:  W J McKenna; J E Deanfield
Journal:  Arch Dis Child       Date:  1984-10       Impact factor: 3.791

10.  [Hypertrophic cardiomyopathy associated with Noonan's syndrome and membranous aortic subvalvular stenosis associated with Turner's syndrome. Report of 2 clinical cases].

Authors:  E Perrotta Scaravilli; D Pontillo; F Pennacchia; A Boccanelli; C Greco; P Lo Schiavo
Journal:  G Ital Cardiol       Date:  1987-09
View more
  13 in total

Review 1.  The cardiofaciocutaneous syndrome.

Authors:  A Roberts; J Allanson; S K Jadico; M I Kavamura; J Noonan; J M Opitz; T Young; G Neri
Journal:  J Med Genet       Date:  2006-07-06       Impact factor: 6.318

2.  Hypertrophic cardiomyopathy.

Authors:  M Burch
Journal:  Arch Dis Child       Date:  1994-12       Impact factor: 3.791

3.  Noonan's cardiomyopathy: a non-hypertrophic variant.

Authors:  R A Cooke; J B Chambers; P V Curry
Journal:  Br Heart J       Date:  1994-06

4.  The natural history of Noonan syndrome: a long-term follow-up study.

Authors:  A C Shaw; K Kalidas; A H Crosby; S Jeffery; M A Patton
Journal:  Arch Dis Child       Date:  2006-09-21       Impact factor: 3.791

5.  Inducible Pluripotent Stem Cell-Derived Cardiomyocytes Reveal Aberrant Extracellular Regulated Kinase 5 and Mitogen-Activated Protein Kinase Kinase 1/2 Signaling Concomitantly Promote Hypertrophic Cardiomyopathy in RAF1-Associated Noonan Syndrome.

Authors:  Fabrice Jaffré; Clint L Miller; Anne Schänzer; Todd Evans; Amy E Roberts; Andreas Hahn; Maria I Kontaridis
Journal:  Circulation       Date:  2019-06-05       Impact factor: 29.690

6.  A regional study of presentation and outcome of hypertrophic cardiomyopathy in infants.

Authors:  J R Skinner; A Manzoor; A M Hayes; H S Joffe; R P Martin
Journal:  Heart       Date:  1997-03       Impact factor: 5.994

7.  Hypertrophic cardiomyopathy in Noonan Syndrome closely mimics familial hypertrophic cardiomyopathy due to sarcomeric mutations.

Authors:  Lucy E Hudsmith; Steffen E Petersen; Jane M Francis; Matthew D Robson; Hugh Watkins; Stefan Neubauer
Journal:  Int J Cardiovasc Imaging       Date:  2005-11-03       Impact factor: 2.357

8.  Noonan syndrome: structural abnormalities of the mitral valve causing subaortic obstruction.

Authors:  B Marino; M G Gagliardi; M C Digilio; B Polletta; S Grazioli; D Agostino; A Giannotti; B Dallapiccola
Journal:  Eur J Pediatr       Date:  1995-12       Impact factor: 3.183

9.  Cardiomyopathies in Noonan syndrome and the other RASopathies.

Authors:  Bruce D Gelb; Amy E Roberts; Marco Tartaglia
Journal:  Prog Pediatr Cardiol       Date:  2015-07-01

10.  Unusual combination of congenital heart defects in an infant with Noonan syndrome.

Authors:  L R Feit; K Hansen; C E Oyer; J C Werner
Journal:  Pediatr Cardiol       Date:  1995 Mar-Apr       Impact factor: 1.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.